O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/17/2021ACC: 0001209191-21-021300
Officer· Chief Medical Officer
Since Jun 2018
+198.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
198.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+99.00
Price / share
$16.22
Trade value
$1.61K
% of position
2.8%
3/15/2021
3.51K→3.61K
Total
Net shares
+99.00
Net value
$1.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2021 | A · Award | +99.00 | $16.22 | $1.61K | 2.8% | 3.51K | 3.61K |
| Total | +99.00 | $1.61K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
99.00 shares
Shares
+99.00
Strike price
19.08
Held after
99.00
Exercisable
—
3/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock99.00 shares | 3/15/2021 | A · Award | +99.00 | 19.08 | — | 99.00 |